|
1. Global Industry Analysts Inc. Apnea monitors market to reach $382 million by 2015, according to new report by Global Industry Analysts Inc.
2. American Hospital Association. The impact of the economic crisis on health services for patients and communities. Washington D.C. Available from: URL: www.aha.org/aha/content/2009/pdf/090311econcrisisdatabank.pdf.
3. Wachovia Capital Markets LLC. Q4 2008 HME sleep & wound care survey. Dallas, TX: HME Business. Available from: URL: http://hme-business.com/Whitepapers/2008/10/Q4-2008-HME-Business-Wachovia-Sleep-and-Wound-Care-Survey.aspx.
4. Berry RB, Hill G, Thompson L, McLaurin V. Portable monitoring and autotitration versus polysomnography for the diagnosis and treatment of sleep apnea. Sleep. 2008;31(10):1423-31.
5. Clinicaltrials.gov. Bethesda, MD: U.S. National Library of Medicine; 2009. Cost effectiveness of ambulatory management for veterans with sleep apnea (VSATT) Available from: URL: http://clinicaltrials.gov/ct2/show/NCT00880165. ClinicalTrials.gov Identifier: NCT00880165
6. Clinicaltrials.gov. Bethesda, MD: U.S. National Library of Medicine; 2009. Portable monitoring for diagnosis and management of sleep apnea (HomePAP) Available from: URL: http://clinicaltrials.gov:80/ct2/show/NCT00642486. ClinicalTrials.gov Identifier: NCT00642486
7. Kakkar RK, Berry RB. Positive airway pressure treatment for obstructive sleep apnea. Chest. 2007;132(3);1057-72.
8. Richards D, Bartlett DJ, Wong K, Malouff J, Grunstein RR. Increased adherence to CPAP with a group cognitive behavioral treatment intervention: a randomized trial. Sleep. 2007;30(5):635-40.
9. Means MK, Edinger JD. Graded exposure therapy for addressing claustrophobic reactions to continuous positive airway pressure: a case series report. Behav Sleep Med. 2007;5(2):105-16.
10. Clinicaltrials.gov. Bethesda, MD: U.S. National Library of Medicine; 2009. Evaluating behavioral treatments to improve adherence to continuous positive airway pressure (CPAP) therapy in people with obstructive sleep apnea (The BREATHE Study) Available from: URL: http://clinicaltrials.gov/ct2/show/NCT00623246. ClinicalTrials.gov Identifier: NCT00623246
11. Arzt M, Wensel R, Montalvan S, Schichtl T, Schroll S, Budweiser S, et. al. Effects of dynamic bilevel positive airway pressure support on central sleep apnea in men with heart failure. Chest. 2008;134(1):61-6.
12. Hwang D, Patel A, Chen G, Ayappa I, Rapoport DM. Nasal EPAP - physiologic mechanism of action. June 9, 2009, poster presentation at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies. Abstract 0591.
13. Abreu A, Doshi R, Loomas B, Westbrook P. Modeling the effectiveness of treatments for obstructive sleep apnea/hypopnea. June 09, 2009, poster presentation at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies. Abstract 0599.
14. Westbrook P, Doshi R, Loomas B. Success rates of nasal expiratory positive airway pressure (nEPAP) via expiratory resistive load for the treatment of obstructive sleep apnea. June 9, 2009, poster presentation at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies. Abstract 0570.
Return to the article.
|